Interleukin-1β causes anxiety by Interacting with the endocannabinoid system

Journal of Neuroscience

Volumn 32, Issue 40, 2012, Pages 13896-13905

  Rossi, Silvia ^a,b   Sacchetti, Lucia ^c   Napolitano, Francesco ^d,e   De Chiara, Valentina ^a,b   Motta, Caterina ^a,b   Studer, Valeria ^a,b   Musella, Alessandra ^a,b   Barbieri, Francesca ^a,b   Bari, Monica ^c   Bernardi, Giorgio ^a,b   Maccarrone, Mauro ^b,f   Usiello, Alessandro ^d,e,g   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF TERAMO   (Italy)

^g EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CANNABINOID 1 RECEPTOR; CHOLESTEROL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROPHYSIOLOGY; LIPID RAFT; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; STRESS; SYNAPSE;

ANIMALS; ANXIETY; CHOLESTEROL; CORPUS STRIATUM; DOMINANCE-SUBORDINATION; ENDOCANNABINOIDS; EXPLORATORY BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PATCH-CLAMP TECHNIQUES; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL; TRPV CATION CHANNELS;

EID: 84866980738     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1515-12.2012     Document Type: Article

References (63)

1. Bari M, Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280:12212-12220. CrossRef Medline
2. Barnum CJ, Eskow KL, Dupre K, Blandino P Jr, Deak T, Bishop C (2008) Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta. Neuroscience 156: 30-41. CrossRef Medline
3. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868. CrossRef Medline
4. Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, Chan K, Manners MT, Samad TA, Kennedy JD, Bingham B, Whiteside GT (2010) Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis 39:148-155. CrossRef Medline
5. Breder CD, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, Teng M, Saper CB (1994) Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A 91:11393-11397. CrossRef Medline
6. Campos AC, Guimarães FS (2009) Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 33:1517-1521. CrossRef Medline
7. Capuron L, Ravaud A, Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 18:2143-2151. Medline
8. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2- adrenergic G protein-coupled receptor. Science 318:1258-1265. CrossRef Medline
9. Chung YC, Kim SR, Jin BK (2010) Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J Immunol 185: 1230-1237. CrossRef Medline
10. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56. CrossRef Medline
11. De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D (2010a) Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 35:374-387. CrossRef Medline
12. De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D (2010b) Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci 30:8127-8137. CrossRef Medline
13. Eisch AJ, Bolaños CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54:994-1005. CrossRef Medline
14. Favilla C, Abel T, Kelly MP (2008) Chronic Gαs signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J Neurosci 28:13952-13956. CrossRef Medline
15. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620-18625. CrossRef Medline
16. Goeb JL, Even C, Nicolas G, Gohier B, Dubas F, Garré JB (2006) Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry 21:186-193. CrossRef Medline
17. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13:717-728. CrossRef Medline
18. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, Ferrell RE, Goldman D, Manuck SB (2009) Divergent effects of genetic variation in endocannabinoid signaling on human threatand reward-related brain function. Biol Psychiatry 66:9-16. CrossRef Medline
19. Hill MN, Gorzalka BB (2009) Impairments in endocannabinoid signaling and depressive illness. JAMA 301:1165-1166. CrossRef Medline
20. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47:345-358. CrossRef Medline
21. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81. CrossRef Medline
22. Kim KS, Lee KW, Baek IS, Lim CM, Krishnan V, Lee JK, Nestler EJ, Han PL (2008) Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J Neurochem 107:105-115. CrossRef Medline
23. Koo JW, Duman RS (2009) Interleukin-1 receptor-null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 456:39-43. CrossRef Medline
24. Layé S, Parnet P, Goujon E, Dantzer R (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res 27:157-162. Medline
25. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185. Medline
26. Long-Smith CM, Collins L, Toulouse A, Sullivan AM, Nolan YM (2010) Interleukin-1 contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro. J Neuroimmunol 226:20-26. CrossRef Medline
27. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11:152-159. CrossRef Medline
28. Maccarrone M, De Chiara V, Gasperi V, Viscomi MT, Rossi S, Oddi S, Molinari M, Musella A, Finazzi-Agrò A, Centonze D (2009) Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. J Neurochem 109:371-381. CrossRef Medline
29. Maccarrone M, Bernardi G, Finazzi-Agrò AF, Centonze D (2011) Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbante. Br J Pharmacol 163:1379-1390. CrossRef Medline
30. Manna SS, Umathe SN (2011) Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam. Brain Res 1425: 75-82. CrossRef Medline
31. Marsch R, Foeller E, Rammes G, Bunck M, Kössl M, Holsboer F, Zieglgänsberger W, Landgraf R, Lutz B, Wotjak CT (2007) Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27:832-839. CrossRef Medline
32. Mathew SJ, Ho S (2006) Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 67 [Suppl 12]:9-13.
33. Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V (2009) Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34:593-606. CrossRef Medline
34. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741. CrossRef Medline
35. Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, Dantzer R, Castanon N (2005) Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 192:537-544. CrossRef Medline
36. Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, Centonze D (2009) TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci 40:89-97. CrossRef Medline
37. Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C, Mataluni G, Bernardi G, Centonze D (2010) Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience 167:864-871. CrossRef Medline
38. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159. CrossRef Medline
39. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC (2010) Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 15:404-414. CrossRef Medline
40. Oprica M, Zhu S, Goiny M, Pham TM, Mohammed AH, Winblad B, Bartfai T, Schultzberg M (2005) Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav Immun 19:223-234. CrossRef Medline
41. Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9-19. CrossRef Medline
42. Patel S, Hillard CJ (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signalling. J Pharmacol Exp Ther 318:304-311. CrossRef Medline
43. Picazo-Juárez G, Romero-Suárez S, Nieto-Posadas A, Llorente I, JaraOseguera A, Briggs M, McIntosh TJ, Simon SA, Ladrón-de-Guevara E, Islas LD, Rosenbaum T (2011) Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel. J Biol Chem 286:24966-24976. CrossRef Medline
44. Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15:384-392. CrossRef Medline
45. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445-452. CrossRef Medline
46. Reiman EM, Fusselman MJ, Fox PT, Raichle ME (1989) Neuroanatomical correlates of anticipatory anxiety. Science 243:1071-1074. CrossRef Medline
47. Rogan MT, Leon KS, Perez DL, Kandel ER (2005) Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse. Neuron 46:309-320. CrossRef Medline
48. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK (2007) GPCR engineering yields high-resolution structural insights into beta2- adrenergic receptor function. Science 318:1266-1273. CrossRef Medline
49. Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D (2008) Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci 28:7284-7292. CrossRef Medline
50. Rossi S, De Chiara V, Musella A, Sacchetti L, Cantarella C, Castelli M, Cavasinni F, Motta C, Studer V, Bernardi G, Cravatt BF, Maccarrone M, Usiello A, Centonze D (2010) Preservation of striatal cannabinoid CB1 receptor function correlates with the anti anxiety effects of fatty acid amide hydrolase inhibition. Mol Pharmacol 78:260-268. CrossRef Medline
51. Snyder SH (2011) Serotonin, cytokines, p11, and depression. Proc Natl Acad Sci U S A 108:8923-8924. CrossRef Medline
52. Starowicz K, Nigam S, Di Marzo V (2007) Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 114:13-33. CrossRef Medline
53. Starowicz K, Cristino L, Di Marzo V (2008) TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 14:42-54. CrossRef Medline
54. Steiner H, Van Waes V, Marinelli M (2010) Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers? Biol Psychiatry 67:592-594. CrossRef Medline
55. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T, Koshimizu H, Kojima M (2007) Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 27: 6417-6427. CrossRef Medline
56. Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, Hamm CW, Montalescot G, Steg PG, Pearson TA, Cohen E, Gaudin C, Job B, Murphy JH, Bhatt DL, Bhatt DL (2010) Rimonabant for prevention of cardiovascular events CRESCENDO: a randomised, multicenter, placebo-controlled trial. Lancet 376:517-523. CrossRef Medline
57. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29-35. CrossRef Medline
58. van Dam AM, Brouns M, Louisse S, Berkenbosch F (1992) Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of nonspecific symptoms of sickness? Brain Res 588:291-296. CrossRef Medline
59. Yoo HK, Kim MJ, Kim SJ, Sung YH, Sim ME, Lee YS, Song SY, Kee BS, Lyoo IK (2005) Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur J Neurosci 22:2089-2094. CrossRef Medline
60. Zhang G, Li Q, Wang L, Chen Y, Wang L, Zhang W (2011) Interleukin-1 enhances the intracellular accumulation of cholesterol by upregulating the expression of low-density lipoprotein receptor and 3-hydroxy-3- methylglutaryl coenzyme A reductase in podocytes. Mol Cell Biochem 346:197-204. CrossRef Medline
61. Zhang HT, Huang Y, Masood A, Stolinski LR, Li Y, Zhang L, Dlaboga D, Jin SL, Conti M, O'Donnell JM (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B PDE4B. Neuropsychopharmacology 33:1611-1623. CrossRef Medline
62. Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121-2131. CrossRef Medline
63. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199-226. CrossRef Medline